{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:17:19Z","timestamp":1772252239043,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22591018"],"award-info":[{"award-number":["22591018"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24790855"],"award-info":[{"award-number":["24790855"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24790952"],"award-info":[{"award-number":["24790952"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research"},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health, Labor, and Welfare, Japan"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.mce.2018.01.007","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T13:27:52Z","timestamp":1517405272000},"page":"89-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Epidermal growth factor receptor\/extracellular signal-regulated kinase pathway enhances mineralocorticoid receptor transcriptional activity through protein stabilization"],"prefix":"10.1016","volume":"473","author":[{"given":"Yuko","family":"Mitsuishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakiko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0284-6072","authenticated-orcid":false,"given":"Kenichi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayano","family":"Murai-Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2485-7028","authenticated-orcid":false,"given":"Toshifumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9589-9140","authenticated-orcid":false,"given":"Mitsuha","family":"Morisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2018.01.007_bib1","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.10001","article-title":"Post-translational modifications of nuclear receptors and human disease","volume":"10","author":"Anbalagan","year":"2012","journal-title":"Nucl. Recept. Signal."},{"key":"10.1016\/j.mce.2018.01.007_bib2","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1128\/MCB.01672-07","article-title":"Epidermal-growth-factor-dependent phosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptor","volume":"28","author":"Bai","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mce.2018.01.007_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.vph.2009.04.004","article-title":"Global upregulation of gene expression associated with renal dysfunction in DOCA-salt-induced hypertensive rats occurs via signaling cascades involving epidermal growth factor receptor: a microarray analysis","volume":"51","author":"Benter","year":"2009","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.mce.2018.01.007_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.mce.2018.01.007_bib5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/379557a0","article-title":"Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors","volume":"379","author":"Daub","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.mce.2018.01.007_bib6","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/HYPERTENSIONAHA.107.103580","article-title":"A\u00a0number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity","volume":"51","author":"Dietz","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2018.01.007_bib7","doi-asserted-by":"crossref","first-page":"R944","DOI":"10.1152\/ajpregu.2001.281.3.R944","article-title":"Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats","volume":"281","author":"Dorrance","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.mce.2018.01.007_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2005.06.038","article-title":"The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis","volume":"186","author":"Dreux","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mce.2018.01.007_bib9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jsbmb.2014.04.015","article-title":"Post-translational modifications of the mineralocorticoid receptor: how to dress the receptor according to the circumstances?","volume":"143","author":"Faresse","year":"2014","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2018.01.007_bib10","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1096\/fj.12-209924","article-title":"Differential ubiquitylation of the mineralocorticoid receptor is regulated by phosphorylation","volume":"26","author":"Faresse","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.mce.2018.01.007_bib11","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.biopha.2006.07.082","article-title":"Post-translational modifications of steroid receptors","volume":"60","author":"Faus","year":"2006","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mce.2018.01.007_bib12","doi-asserted-by":"crossref","first-page":"R878","DOI":"10.1152\/ajpregu.2001.281.3.R878","article-title":"Mineralocorticoids upregulate arterial contraction to epidermal growth factor","volume":"281","author":"Florian","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.mce.2018.01.007_bib13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1146\/annurev-pharmtox-070115-095427","article-title":"EGFR transactivation: mechanisms, pathophysiology and potensial therapies in cardiavascular system","volume":"56","author":"Forrester","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.mce.2018.01.007_bib14","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1096\/fj.03-0702fje","article-title":"Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition","volume":"18","author":"Francois","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.mce.2018.01.007_bib15","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","article-title":"Mechanisms of mineralocorticoid action","volume":"46","author":"Fuller","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2018.01.007_bib16","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.steroids.2011.09.004","article-title":"Diverse immunostaining patterns of mineralocorticoid receptor monoclonal antibodies","volume":"76","author":"Gomez-Sanchez","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2018.01.007_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.mce.2011.07.045","article-title":"Interaction between mineralocorticoid receptor and epidermal growth factor receptor signaling","volume":"350","author":"Grossmann","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2018.01.007_bib18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.steroids.2009.10.006","article-title":"Interaction between mineralocorticoid receptor and cAMP\/CREB signaling","volume":"75","author":"Grossmann","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2018.01.007_bib19","doi-asserted-by":"crossref","first-page":"E1790","DOI":"10.1152\/ajpendo.00708.2006","article-title":"Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter","volume":"292","author":"Grossmann","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2018.01.007_bib20","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/en.2010-0099","article-title":"The mineralocorticoid receptor is a constitutive nuclear factor in cardiomyocytes due to hyperactive nuclear localization signals","volume":"151","author":"Hernandez-Diaz","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2018.01.007_bib21","first-page":"1","article-title":"EGF receptor as a drug target in arterial hypertension","volume":"9","author":"J","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.mce.2018.01.007_bib22","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.bcp.2008.01.003","article-title":"Transactivation of epidermal growth factor receptor in vascular and renal systems in rats with experimental hyperleptinemia: role in leptin-induced hypertension","volume":"75","author":"Jamroz-Wisniewska","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mce.2018.01.007_bib23","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/01.HYP.0000047104.42047.9B","article-title":"Antisense to epidermal growth factor receptor prevents the development of left ventricular hypertrophy","volume":"41","author":"Kagiyama","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2018.01.007_bib24","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/01.CIR.0000030181.63741.56","article-title":"Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense","volume":"106","author":"Kagiyama","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2018.01.007_bib25","doi-asserted-by":"crossref","first-page":"35049","DOI":"10.1074\/jbc.M304913200","article-title":"Epidermal growth factor receptor transactivation is regulated by glucose in vascular smooth muscle cells","volume":"278","author":"Konishi","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2018.01.007_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1210\/me.2003-0331","article-title":"Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word?","volume":"18","author":"Lange","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2018.01.007_bib27","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1073\/pnas.97.3.1032","article-title":"Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome","volume":"97","author":"Lange","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2018.01.007_bib28","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s11064-005-8837-5","article-title":"Epidermal growth factor receptor is a common element in the signaling pathways activated by cell volume changes in isosmotic, hyposmotic or hyperosmotic conditions","volume":"30","author":"Lezama","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.mce.2018.01.007_bib29","doi-asserted-by":"crossref","first-page":"8084","DOI":"10.1074\/jbc.M109.053371","article-title":"NF-YC functions as a corepressor of agonist-bound mineralocorticoid receptor","volume":"285","author":"Murai-Takeda","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2018.01.007_bib30","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/hr.2011.35","article-title":"Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats","volume":"34","author":"Nakamura","year":"2011","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.mce.2018.01.007_bib31","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1210\/me.2005-0089","article-title":"The mineralocorticoid receptor: a journey exploring its diversity and specificity of action","volume":"19","author":"Pascual-Le Tallec","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2018.01.007_bib32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11906-007-0066-7","article-title":"Resistant hypertension and aldosteronism","volume":"9","author":"Pimenta","year":"2007","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.mce.2018.01.007_bib33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.mce.2018.01.007_bib34","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2018.01.007_bib35","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.mce.2018.01.007_bib36","doi-asserted-by":"crossref","first-page":"20989","DOI":"10.1074\/jbc.M802392200","article-title":"Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer","volume":"283","author":"Ponguta","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2018.01.007_bib37","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1210\/me.2002-0378","article-title":"Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors","volume":"17","author":"Qiu","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2018.01.007_bib38","doi-asserted-by":"crossref","first-page":"21933","DOI":"10.1016\/S0021-9258(17)31735-0","article-title":"Epidermal growth factor and lipopolysaccharide activate Stat3 transcription factor in mouse liver","volume":"269","author":"Ruff-Jamison","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2018.01.007_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1269\/jrr.10069","article-title":"Therapeutic effects of recombinant human epidermal growth factor (rhEGF) in a murine model of concurrent chemo- and radiotherapy-induced oral mucositis","volume":"51","author":"Ryu","year":"2010","journal-title":"J.\u00a0Radiat. Res."},{"key":"10.1016\/j.mce.2018.01.007_bib40","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.cellsig.2013.07.007","article-title":"Induction of renal fibrotic genes by TGF-beta1 requires EGFR activation, p53 and reactive oxygen species","volume":"25","author":"Samarakoon","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.mce.2018.01.007_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/1056-8719(92)90036-Z","article-title":"The pathogenesis of DOCA-salt hypertension","volume":"27","author":"Schenk","year":"1992","journal-title":"J.\u00a0Pharmacol. Toxicol. Meth."},{"key":"10.1016\/j.mce.2018.01.007_bib42","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.mce.2018.01.007_bib43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0165-6147(03)00079-8","article-title":"A\u00a0central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophy","volume":"24","author":"Shah","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mce.2018.01.007_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1753465815617871","article-title":"Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches","volume":"10","author":"Shea","year":"2016","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.mce.2018.01.007_bib45","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ajh.2011.245","article-title":"Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension","volume":"25","author":"Shibata","year":"2012","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.mce.2018.01.007_bib46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semcdb.2014.03.003","article-title":"From wavy hair to naked proteins: the role of transforming growth factor alpha in health and disease","volume":"28","author":"Singh","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.mce.2018.01.007_bib47","doi-asserted-by":"crossref","first-page":"776","DOI":"10.7326\/0003-4819-150-11-200906020-00005","article-title":"Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension","volume":"150","author":"Sowers","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.mce.2018.01.007_bib48","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11906-010-0126-2","article-title":"Mineralocorticoid receptor antagonists and the metabolic syndrome","volume":"12","author":"Tirosh","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.mce.2018.01.007_bib49","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ijo.2011.232","article-title":"Role of mineralocorticoid receptor\/Rho\/Rho-kinase pathway in obesity-related renal injury","volume":"36","author":"Tokuyama","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.mce.2018.01.007_bib50","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.05012","article-title":"The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology","volume":"5","author":"Viengchareun","year":"2007","journal-title":"Nucl. Recept. Signal."},{"key":"10.1016\/j.mce.2018.01.007_bib51","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/01.ASN.0000017902.77985.84","article-title":"Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: role of Renin genes","volume":"13","author":"Wang","year":"2002","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.mce.2018.01.007_bib52","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s001090050241","article-title":"Ligand-independent activation of steroid hormone receptors","volume":"76","author":"Weigel","year":"1998","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.mce.2018.01.007_bib53","doi-asserted-by":"crossref","first-page":"F314","DOI":"10.1152\/ajprenal.00003.2005","article-title":"Enhanced expression of EGF receptor in a model of salt-sensitive hypertension","volume":"289","author":"Ying","year":"2005","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.mce.2018.01.007_bib54","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1081\/ERC-200043783","article-title":"Proteasome-mediated mineralocorticoid receptor degradation attenuates transcriptional response to aldosterone","volume":"30","author":"Yokota","year":"2004","journal-title":"Endocr. Res."},{"key":"10.1016\/j.mce.2018.01.007_bib55","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1074\/jbc.M607741200","article-title":"Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9","volume":"282","author":"Yokota","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2018.01.007_bib56","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1210\/en.2004-0005","article-title":"Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone\/salt-treated rats","volume":"145","author":"Young","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2018.01.007_bib57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0039-128X(96)00020-7","article-title":"Mineralocorticoids, salt, hypertension: effects on the heart","volume":"61","author":"Young","year":"1996","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2018.01.007_bib58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720718300170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720718300170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:05:49Z","timestamp":1759586749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720718300170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":58,"alternative-id":["S0303720718300170"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2018.01.007","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidermal growth factor receptor\/extracellular signal-regulated kinase pathway enhances mineralocorticoid receptor transcriptional activity through protein stabilization","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2018.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}